These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2144963)

  • 21. Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.
    Fitzsimmons SA; Lewis AD; Riley RJ; Workman P
    Carcinogenesis; 1994 Aug; 15(8):1503-10. PubMed ID: 8055626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide.
    Junnotula V; Sarkar U; Sinha S; Gates KS
    J Am Chem Soc; 2009 Jan; 131(3):1015-24. PubMed ID: 19117394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL
    Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233).
    Laderoute K; Wardman P; Rauth AM
    Biochem Pharmacol; 1988 Apr; 37(8):1487-95. PubMed ID: 3128984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective interaction of tirapazamine with DNA bases and DNA. A comparison of cyclic voltammetry and electrolysis techniques.
    Tocher JH
    Free Radic Res; 2001 Aug; 35(2):159-66. PubMed ID: 11697196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Putative electron-affinic radiosensitizers and markers of hypoxic tissue: Synthesis and preliminary in vitro biological characterization of C3-amino-substituted benzotriazine dioxides (BTDOs).
    Elsaidi HR; Yang XH; Ahmadi F; Weinfeld M; Wiebe LI; Kumar P
    Eur J Med Chem; 2019 Mar; 165():216-224. PubMed ID: 30684798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct evidence for bimodal DNA damage induced by tirapazamine.
    Daniels JS; Gates KS; Tronche C; Greenberg MM
    Chem Res Toxicol; 1998 Nov; 11(11):1254-7. PubMed ID: 9815184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
    Siim BG; Menke DR; Dorie MJ; Brown JM
    Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.
    Anderson RF; Shinde SS; Hay MP; Denny WA
    J Am Chem Soc; 2006 Jan; 128(1):245-9. PubMed ID: 16390153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-electrode amperometric detection for the determination of SR4233 and its metabolites with microbore liquid chromatography.
    Liang XZ; Palsmeier RK; Lunte CE
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):113-9. PubMed ID: 8833973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.
    Hanauske AR; Ross M; Degen D; Hilsenbeck SG; Von Hoff DD
    Eur J Cancer; 1993; 29A(3):423-5. PubMed ID: 8398345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.
    Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
    J Am Chem Soc; 2003 Jan; 125(3):748-56. PubMed ID: 12526674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitro.
    Chinje EC; Cowen RL; Feng J; Sharma SP; Wind NS; Harris AL; Stratford IJ
    Mol Pharmacol; 2003 Jun; 63(6):1248-55. PubMed ID: 12761334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.
    Stratford IJ; Stephens MA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):973-6. PubMed ID: 2495261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Takahashi M; Abe M
    Br J Cancer Suppl; 1996 Jul; 27():S61-4. PubMed ID: 8763848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug.
    Priyadarsini KI; Tracy M; Wardman P
    Free Radic Res; 1996 Nov; 25(5):393-9. PubMed ID: 8902537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of tirapazamine by multiple reductases in the nucleus.
    Delahoussaye YM; Evans JW; Brown JM
    Biochem Pharmacol; 2001 Nov; 62(9):1201-9. PubMed ID: 11705453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrochemical characteristics of five quinolone drugs and their effect on DNA damage and repair in Escherichia coli.
    Thomas A; Tocher J; Edwards DI
    J Antimicrob Chemother; 1990 May; 25(5):733-44. PubMed ID: 2165050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.